https://www.pharma-zeitung.de/agenus-meldet-auf-der-igcs-2026-eine-geschatzte-dr.17412.php
Agenus meldet auf der IGCS 2026 eine geschätzte Dreijahresüberlebensrate von 48 % mit BOT+BAL bei...
agenusmeldetaufderigcs
https://finlo.io/stock-calculator/AGEN
Agenus Stock Calculator
Use the Agenus stock calculator to calculate the total returns if you had invested in Agenus (AGEN).
agenusstockcalculator
https://tickeron.com/ticker/AGEN/forecasts-predictions/
Agenus (AGEN) stock Forecast, Price Targets and Analysts Predictions - Tickeron.com
stock forecastagenuspricetargetsanalysts
https://pressreleasehub.pa.media/article/agenus-reports-landmark-botbal-data-showing-33-three-year-overall-survival-in-refractory-mss-metastatic-colorectal-cancer-without-active-liver-metastases-at-esmo-gi-2026-78260.html
Agenus Reports Landmark BOT+BAL Data Showing 33% Three-Year Overall Survival in Refractory MSS...
overall survivalagenusreportslandmarkbot
https://eciks.org/13609-44241-agenus-340-million-colon-cancer-trial
Biotech firm Agenus raises up to $340 million in oversubscribed private placement to advance...
Jul 14, 2026 - The $340M funding will support a global Phase 3 trial enrolling 850 patients, targeting a market with no new therapies approved in over 20 years.
raises upprivate placementbiotechfirmagenus
https://www.ventureline.com/financial-statement-analysis/AGEN/abbvie-inc-financial-statement-analysis/
Agenus Inc. - AGEN - Financial Statement Analysis
financial statement analysisagenusinc
https://windpress.info/en/press-release/1198535/agenus-to-provide-second-quarter-2026-financial-report-and-development-update
Press release: Agenus to Provide Second Quarter 2026 Financial Report and Development Update
Jul 28, 2026 - Agenus Inc. (“Agenus”) (Nasdaq: AGEN), a leader in immuno-oncology, today announced that the Company will release its second quarter 2026 financial results...
press releasesecond quarterfinancial reportagenusprovide
https://technews.org/tag/agenus-inc/
Agenus Inc. – Tech News
tech newsagenusinc